Microbial Epidemiology of the Cystic Fibrosis Airways: Past, Present, and Future
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Microbial Epidemiology of the Cystic Fibrosis Airways: Past, Present, and Future
Authors
Keywords
-
Journal
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
Volume -, Issue -, Pages -
Publisher
Georg Thieme Verlag KG
Online
2023-01-10
DOI
10.1055/s-0042-1758732
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Managing Pulmonary Infection in Adults With Cystic Fibrosis: Adult Cystic Fibrosis Series
- (2022) Heather D. Green et al. CHEST
- Commensal Bacteria in the Cystic Fibrosis Airway Microbiome Reduce P. aeruginosa Induced Inflammation
- (2022) Andrew Tony-Odigie et al. Frontiers in Cellular and Infection Microbiology
- Same Game, Different Players: Emerging Pathogens of the CF Lung
- (2021) Alexa D. Gannon et al. mBio
- Extended-culture and culture-independent molecular analysis of the airway microbiota in cystic fibrosis following CFTR modulation with ivacaftor
- (2021) Gisli G. Einarsson et al. Journal of Cystic Fibrosis
- PROMISE: Working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy
- (2021) Dave P. Nichols et al. Journal of Cystic Fibrosis
- Azithromycin and the microbiota of cystic fibrosis sputum
- (2021) Nicole Acosta et al. BMC MICROBIOLOGY
- The Gut-Lung Axis in Cystic Fibrosis
- (2021) Courtney E. Price et al. JOURNAL OF BACTERIOLOGY
- Comparing encounter-based and annualized chronic pseudomonas infection definitions in cystic fibrosis
- (2021) Margaret Rosenfeld et al. Journal of Cystic Fibrosis
- Cystic fibrosis
- (2021) Michal Shteinberg et al. LANCET
- Current and Emerging Therapies to Combat Cystic Fibrosis Lung Infections
- (2021) Jim Manos Microorganisms
- Staphylococcus aureus and Cystic Fibrosis—A Close Relationship. What Can We Learn from Sequencing Studies?
- (2021) Christine Rumpf et al. Pathogens
- Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT
- (2021) Simon C Langton Hewer et al. HEALTH TECHNOLOGY ASSESSMENT
- Inter-species interactions alter antibiotic efficacy in bacterial communities
- (2021) Michael J. Bottery et al. ISME Journal
- A restructuring of microbiome niche space is associated with Elexacaftor-Tezacaftor-Ivacaftor therapy in the cystic fibrosis lung
- (2021) Lo M. Sosinski et al. Journal of Cystic Fibrosis
- 493: Effects of elexacaftor/tezacaftor/ivacaftor on antimicrobial functions of CF neutrophils
- (2021) F. Robledo et al. Journal of Cystic Fibrosis
- Impact of Achromobacter spp. isolation on clinical outcomes in children with cystic fibrosis
- (2021) Birce Sunman et al. PEDIATRIC PULMONOLOGY
- CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
- (2020) Miquéias Lopes-Pacheco Frontiers in Pharmacology
- Longitudinal Associations of the Cystic Fibrosis Airway Microbiome and Volatile Metabolites: A Case Study
- (2020) Andrea Hahn et al. Frontiers in Cellular and Infection Microbiology
- Antibiotic Treatment and Age Are Associated With Staphylococcus aureus Carriage Profiles During Persistence in the Airways of Cystic Fibrosis Patients
- (2020) Corinna Westphal et al. Frontiers in Microbiology
- Lung function and microbiota diversity in cystic fibrosis
- (2020) Leah Cuthbertson et al. Microbiome
- Combining bacteriophages with cefiderocol and meropenem/vaborbactam to treat a pan‐drug resistant Achromobacter species infection in a pediatric cystic fibrosis patient
- (2020) Andrew B. Gainey et al. PEDIATRIC PULMONOLOGY
- High-Resolution Longitudinal Dynamics of the Cystic Fibrosis Sputum Microbiome and Metabolome through Antibiotic Therapy
- (2020) Ruma Raghuvanshi et al. mSystems
- Activity of airway antimicrobial peptides against cystic fibrosis pathogens
- (2020) Andrea Cabak et al. Pathogens and Disease
- Cefiderocol for the Treatment of Adult and Pediatric Patients with Cystic Fibrosis and Achromobacter xylosoxidans Infections
- (2020) Nathaniel C Warner et al. CLINICAL INFECTIOUS DISEASES
- Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis
- (2020) Elio Rossi et al. NATURE REVIEWS MICROBIOLOGY
- Microbiome networks and change-point analysis reveal key community changes associated with cystic fibrosis pulmonary exacerbations
- (2019) Mehdi Layeghifard et al. npj Biofilms and Microbiomes
- Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: A randomized multicenter study
- (2019) Daniela Dolce et al. PLoS One
- Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: A systematic review
- (2019) Ranjani Somayaji et al. Journal of Cystic Fibrosis
- Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli
- (2019) George G. Zhanel et al. DRUGS
- Shifting Landscape of Airway Infection in Early Cystic Fibrosis
- (2019) Jordana E Hoppe et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface
- (2019) Sankalp Malhotra et al. CLINICAL MICROBIOLOGY REVIEWS
- Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis–data from the European cystic fibrosis society patient registry
- (2019) Elpis Hatziagorou et al. Journal of Cystic Fibrosis
- The impact of CFTR modulator therapies on CF airway microbiology
- (2019) Geraint B. Rogers et al. Journal of Cystic Fibrosis
- Deciphering the Ecology of Cystic Fibrosis Bacterial Communities: Towards Systems-Level Integration
- (2019) Annamaria Bevivino et al. TRENDS IN MOLECULAR MEDICINE
- Antimicrobial Treatment of Staphylococcus aureus in Patients With Cystic Fibrosis
- (2019) Susanna Esposito et al. Frontiers in Pharmacology
- Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial
- (2019) Harry G M Heijerman et al. LANCET
- Cystic Fibrosis: Pathophysiology of Lung Disease
- (2019) Christelle Bergeron et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Clinical Outcomes Associated with Escherichia coli Infections in Adults with Cystic Fibrosis: A Cohort Study
- (2019) B D Edwards et al. Open Forum Infectious Diseases
- Prevalence and clinical associations of Staphylococcus aureus small-colony variant respiratory infection in children with cystic fibrosis (SCVSA): a multicentre, observational study
- (2019) Daniel J Wolter et al. Lancet Respiratory Medicine
- Tezacaftor/Ivacaftor in Subjects with Cystic Fibrosis and F508del/F508del-CFTR or F508del/G551D-CFTR
- (2018) Scott H. Donaldson et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Changing Rates of Chronic Pseudomonas aeruginosa Infections in Cystic Fibrosis: A Population-Based Cohort Study
- (2018) Matthew R Crull et al. CLINICAL INFECTIOUS DISEASES
- Anaerobic bacteria cultured from cystic fibrosis airways correlate to milder disease: a multisite study
- (2018) Marianne S. Muhlebach et al. EUROPEAN RESPIRATORY JOURNAL
- Good cop, bad cop: anaerobes in cystic fibrosis airways
- (2018) Lindsay J. Caverly et al. EUROPEAN RESPIRATORY JOURNAL
- ECFS best practice guidelines: the 2018 revision
- (2018) Carlo Castellani et al. Journal of Cystic Fibrosis
- Effect of respiratory Achromobacter spp. infection on pulmonary function in patients with cystic fibrosis
- (2018) R. Recio et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Stenotrophomonas maltophilia : A marker of lung disease severity
- (2018) Laura Berdah et al. PEDIATRIC PULMONOLOGY
- Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis
- (2018) Lisa A. Carmody et al. PLoS One
- The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial
- (2018) Katherine Ronchetti et al. Lancet Respiratory Medicine
- Tracking Polymicrobial Metabolism in Cystic Fibrosis Airways: Pseudomonas aeruginosa Metabolism and Physiology Are Influenced by Rothia mucilaginosa-Derived Metabolites
- (2018) Bei Gao et al. mSphere
- Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis
- (2018) Michael D. Parkins et al. CLINICAL MICROBIOLOGY REVIEWS
- Exhaled Breath Condensate
- (2018) Michael D. Davis et al. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Eradication of persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis
- (2018) Rebecca Dezube et al. Journal of Cystic Fibrosis
- Biology and management of methicillin resistant Staphylococcus aureus in cystic fibrosis
- (2018) Nour Akil et al. PEDIATRIC PULMONOLOGY
- Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis
- (2018) Nicole Acosta et al. THORAX
- Ivacaftor, a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator, Enhances Ciprofloxacin Activity Against Pseudomonas aeruginosa
- (2018) Do-Yeon Cho et al. American Journal of Rhinology & Allergy
- Airway microbiota across age and disease spectrum in cystic fibrosis
- (2017) Edith T. Zemanick et al. EUROPEAN RESPIRATORY JOURNAL
- Activity of innate antimicrobial peptides and ivacaftor against clinical cystic fibrosis respiratory pathogens
- (2017) Joanna E. Payne et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Prevalence and Outcomes of Achromobacter Species Infections in Adults with Cystic Fibrosis: a North American Cohort Study
- (2017) B. D. Edwards et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Effectiveness of a stepwise Pseudomonas aeruginosa eradication protocol in children with cystic fibrosis
- (2017) Ana C. Blanchard et al. Journal of Cystic Fibrosis
- Exhaled breath analysis: a review of ‘breath-taking’ methods for off-line analysis
- (2017) Oluwasola Lawal et al. Metabolomics
- Incident Stenotrophomonas maltophilia infection and lung function decline in cystic fibrosis
- (2017) Emily E. Barsky et al. PEDIATRIC PULMONOLOGY
- The lower airway microbiota in early cystic fibrosis lung disease: a longitudinal analysis
- (2017) Katherine B Frayman et al. THORAX
- Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches
- (2017) Viola C. Scoffone et al. Frontiers in Microbiology
- The effects of inhaled aztreonam on the cystic fibrosis lung microbiome
- (2017) Alya A. Heirali et al. Microbiome
- Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details
- (2017) Rounak Feigelman et al. Microbiome
- Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis
- (2017) Fiona J. Whelan et al. PLoS One
- The fermentation product 2,3-butanediol alters P. aeruginosa clearance, cytokine response and the lung microbiome
- (2016) Mytien Nguyen et al. ISME Journal
- Microbial colonization and lung function in adolescents with cystic fibrosis
- (2016) Andreas Hector et al. Journal of Cystic Fibrosis
- Cystic Fibrosis
- (2016) Edith T. Zemanick et al. PEDIATRIC CLINICS OF NORTH AMERICA
- Long-term clinical outcomes of ‘Prairie Epidemic Strain’ Pseudomonas aeruginosa infection in adults with cystic fibrosis
- (2016) Ranjani Somayaji et al. THORAX
- Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial
- (2016) Marianne Sponer Muhlebach et al. THORAX
- Convergence of Staphylococcus aureus Persister and Biofilm Research: Can Biofilms Be Defined as Communities of Adherent Persister Cells?
- (2016) Elaine M. Waters et al. PLoS Pathogens
- An “Unlikely” Pair: The Antimicrobial Synergy of Polymyxin B in Combination with the Cystic Fibrosis Transmembrane Conductance Regulator Drugs KALYDECO and ORKAMBI
- (2016) Elena K. Schneider et al. ACS Infectious Diseases
- Factors Associated with Worse Lung Function in Cystic Fibrosis Patients with Persistent Staphylococcus aureus
- (2016) Sibylle Junge et al. PLoS One
- Impact of Sustained Eradication of NewPseudomonas aeruginosaInfection on Long-term Outcomes in Cystic Fibrosis
- (2015) Nicole Mayer-Hamblett et al. CLINICAL INFECTIOUS DISEASES
- Erratum: A Winogradsky-based culture system shows an association between microbial fermentation and cystic fibrosis exacerbation
- (2015) Robert A Quinn et al. ISME Journal
- Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention
- (2015) Leah Cuthbertson et al. ISME Journal
- Open label study of inhaled aztreonam for Pseudomonas eradication in children with cystic fibrosis: The ALPINE study
- (2015) H.A.W.M. Tiddens et al. Journal of Cystic Fibrosis
- Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis
- (2015) Michael D. Parkins et al. Journal of Cystic Fibrosis
- Pediatric Cystic Fibrosis Sputum Can Be Chemically Dynamic, Anoxic, and Extremely Reduced Due to Hydrogen Sulfide Formation
- (2015) Elise S. Cowley et al. mBio
- The daily dynamics of cystic fibrosis airway microbiota during clinical stability and at exacerbation
- (2015) Lisa A Carmody et al. Microbiome
- Lung microbiota across age and disease stage in cystic fibrosis
- (2015) Bryan Coburn et al. Scientific Reports
- Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis
- (2014) Steven M. Rowe et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pseudomonas aeruginosa in Cystic Fibrosis Patients With G551D-CFTR Treated With Ivacaftor
- (2014) Sonya L. Heltshe et al. CLINICAL INFECTIOUS DISEASES
- Infections in Patients with Cystic Fibrosis
- (2014) Peter H. Gilligan CLINICS IN LABORATORY MEDICINE
- Pyrosequencing reveals transient cystic fibrosis lung microbiome changes with intravenous antibiotics
- (2014) D. J. Smith et al. EUROPEAN RESPIRATORY JOURNAL
- Antibacterial properties of the CFTR potentiator ivacaftor
- (2014) Leah R. Reznikov et al. Journal of Cystic Fibrosis
- Eradication strategy for persistent methicillin-resistant Staphylococcus aureus infection in individuals with cystic fibrosis—the PMEP trial: study protocol for a randomized controlled trial
- (2014) Mark T Jennings et al. Trials
- Cystic Fibrosis Pulmonary Guidelines
- (2013) Peter J. Mogayzel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Staphylococcus aureus Small-Colony Variants Are Independently Associated With Worse Lung Disease in Children With Cystic Fibrosis
- (2013) Daniel J. Wolter et al. CLINICAL INFECTIOUS DISEASES
- Clinical Application of Volatile Organic Compound Analysis for Detecting Infectious Diseases
- (2013) S. Sethi et al. CLINICAL MICROBIOLOGY REVIEWS
- Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS Patient Registry
- (2013) E. Kerem et al. EUROPEAN RESPIRATORY JOURNAL
- Early treatment with inhaled antibiotics postpones next occurrence of Achromobacter in cystic fibrosis
- (2013) M. Wang et al. Journal of Cystic Fibrosis
- Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients
- (2013) Valerie Waters et al. Journal of Cystic Fibrosis
- Induced sputum compared to bronchoalveolar lavage in young, non-expectorating cystic fibrosis children
- (2013) Hannah Blau et al. Journal of Cystic Fibrosis
- Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations
- (2013) Edith T. Zemanick et al. PLoS One
- Microbiota and Metabolite Profiling Reveal Specific Alterations in Bacterial Community Structure and Environment in the Cystic Fibrosis Airway during Exacerbation
- (2013) Kate B. Twomey et al. PLoS One
- Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation
- (2013) Katherine E Price et al. Microbiome
- Molecular analysis of volatile metabolites released specifically by staphylococcus aureus and pseudomonas aeruginosa
- (2012) Wojciech Filipiak et al. BMC MICROBIOLOGY
- Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective
- (2012) Anders Folkesson et al. NATURE REVIEWS MICROBIOLOGY
- Decade-long bacterial community dynamics in cystic fibrosis airways
- (2012) J. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comparative Efficacy and Safety of 4 Randomized Regimens to Treat Early Pseudomonas aeruginosa Infection in Children With Cystic Fibrosis
- (2011) Miriam M. Treggiari ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE
- Inflammatory Responses to Individual Microorganisms in the Lungs of Children With Cystic Fibrosis
- (2011) C. Gangell et al. CLINICAL INFECTIOUS DISEASES
- Prevalence and genetic diversity of Staphylococcus aureus small-colony variants in cystic fibrosis patients
- (2011) S. Yagci et al. CLINICAL MICROBIOLOGY AND INFECTION
- Update on methicillin-resistant Staphylococcus aureus in cystic fibrosis
- (2011) Elliott C. Dasenbrook CURRENT OPINION IN PULMONARY MEDICINE
- Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients
- (2011) A. Lambiase et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis
- (2011) Valerie Waters et al. EUROPEAN RESPIRATORY JOURNAL
- Review: Staphylococcus aureus and MRSA in cystic fibrosis
- (2011) Christopher H. Goss et al. Journal of Cystic Fibrosis
- Culture Enriched Molecular Profiling of the Cystic Fibrosis Airway Microbiome
- (2011) Christopher D. Sibley et al. PLoS One
- Quantification of methyl thiocyanate in the headspace of Pseudomonas aeruginosa cultures and in the breath of cystic fibrosis patients by selected ion flow tube mass spectrometry
- (2011) Violetta Shestivska et al. RAPID COMMUNICATIONS IN MASS SPECTROMETRY
- Long-term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression alterations
- (2011) Carla P. Coutinho Frontiers in Cellular and Infection Microbiology
- Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary Exacerbation
- (2010) Don B. Sanders et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Stenotrophomonas maltophiliain Cystic Fibrosis
- (2010) Valerie Waters et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The genus Prevotella in cystic fibrosis airways
- (2010) Tyler R. Field et al. ANAEROBE
- The Changing Microbial Epidemiology in Cystic Fibrosis
- (2010) J. J. LiPuma CLINICAL MICROBIOLOGY REVIEWS
- Clonal epidemiology of Pseudomonas aeruginosa in cystic fibrosis
- (2010) Nina Cramer et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities
- (2010) Christopher J van der Gast et al. ISME Journal
- Structural lung changes, lung function, and non-invasive inflammatory markers in cystic fibrosis
- (2010) Charlotte M. H. H. T. Robroeks et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- Microbial Interactions in the Respiratory Tract
- (2010) Timothy F. Murphy et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Longitudinal assessment of health-related quality of life in an observational cohort of patients with cystic fibrosis
- (2010) Gregory S. Sawicki et al. PEDIATRIC PULMONOLOGY
- Metabolomics of Volatile Organic Compounds in Cystic Fibrosis Patients and Controls
- (2010) Charlotte M H H T Robroeks et al. PEDIATRIC RESEARCH
- Cystic Fibrosis Pulmonary Guidelines
- (2009) Patrick A. Flume et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients
- (2009) D. Worlitzsch et al. CLINICAL MICROBIOLOGY AND INFECTION
- Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005
- (2009) F.A. Millar et al. Journal of Cystic Fibrosis
- Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients
- (2009) C.R. Hansen et al. Journal of Cystic Fibrosis
- Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial
- (2009) F. Ratjen et al. THORAX
- Persistent Methicillin-resistantStaphylococcus aureusand Rate of FEV1Decline in Cystic Fibrosis
- (2008) Elliott C. Dasenbrook et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis
- (2008) Michael M. Tunney et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Clinical Characteristics Associated with Isolation of Small-Colony Variants of Staphylococcus aureus and Pseudomonas aeruginosa from Respiratory Secretions of Patients with Cystic Fibrosis
- (2008) M. Schneider et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Impact of Pseudomonas and Staphylococcus Infection on Inflammation and Clinical Status in Young Children with Cystic Fibrosis
- (2008) Scott D. Sagel et al. JOURNAL OF PEDIATRICS
- Molecular Detection of Multiple Emerging Pathogens in Sputa from Cystic Fibrosis Patients
- (2008) Fadi Bittar et al. PLoS One
- A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients
- (2008) C. D. Sibley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discerning the Complexity of Community Interactions Using a Drosophila Model of Polymicrobial Infections
- (2008) Christopher D. Sibley et al. PLoS Pathogens
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started